Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Azzour D. Hazzan"'
Publikováno v:
Journal of Onco-Nephrology. 5:8-12
Background: PARP inhibitors are a new class of drugs that are being widely used in treatment of various cancers including advanced ovarian cancer. Based on new promising data and impending approvals, it is expected that there will be an increased use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::311aa0800dd557dd2acb8ad7f0b625f0
https://doi.org/10.1177/2399369320981386
https://doi.org/10.1177/2399369320981386
Autor:
Jia H. Ng, Jamie S. Hirsch, Rimda Wanchoo, Mala Sachdeva, Vipulbhai Sakhiya, Susana Hong, Kenar D. Jhaveri, Steven Fishbane, Mersema Abate, Hugo Paz Andrade, Richard L. Barnett, Alessandro Bellucci, Madhu C. Bhaskaran, Antonio G. Corona, Bessy Suyin Flores Chang, Mark Finger, Michael Gitman, Candice Halinski, Shamir Hasan, Azzour D. Hazzan, Yuriy Khanin, Aireen Kuan, Varun Madireddy, Deepa Malieckal, Abdulrahman Muzib, Gayatri Nair, Jia Hwei Ng, Rushang Parikh, Daniel W. Ross, Richard Schwarz, Hitesh H. Shah, Purva Sharma, Pravin C. Singhal, Nupur N. Uppal, Vinay V. Nair
Publikováno v:
Kidney International
Given the high risk of infection-related mortality, patients with end-stage kidney disease (ESKD) may be at increased risk with COVID-19. To assess this, we compared outcomes of patients with and without ESKD, hospitalized with COVID-19. This was a r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92595e97ea40e1ab6338ba8e4ebe9ee7
http://europepmc.org/articles/PMC7428720
http://europepmc.org/articles/PMC7428720
Autor:
Jamie S. Hirsch, Jia H. Ng, Daniel W. Ross, Purva Sharma, Hitesh H. Shah, Richard L. Barnett, Azzour D. Hazzan, Steven Fishbane, Kenar D. Jhaveri, Mersema Abate, Hugo Paz Andrade, Alessandro Bellucci, Madhu C. Bhaskaran, Antonio G. Corona, Bessy Flores Chang, Mark Finger, Michael Gitman, Candice Halinski, Shamir Hasan, Susana Hong, Yuriy Khanin, Aireen Kuan, Varun Madireddy, Deepa Malieckal, Abdulrahman Muzib, Gayatri Nair, Vinay V. Nair, Rushang Parikh, Vipulbhai Sakhiya, Mala Sachdeva, Richard Schwarz, Pravin C. Singhal, Nupur N. Uppal, Rimda Wanchoo, null Bessy Suyin Flores Chang, Jia Hwei. Ng
Publikováno v:
Kidney International
The rate of acute kidney injury (AKI) associated with patients hospitalized with Covid-19, and associated outcomes are not well understood. This study describes the presentation, risk factors and outcomes of AKI in patients hospitalized with Covid-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b10544a80d1c52a8f6aa5d0a3ad3e483
Autor:
Anna T. Mathew, Azzour D. Hazzan, Candice Halinski, Meng Zhang, Vipul Sakhiya, Jamil Ibrahim, Steven Fishbane
Publikováno v:
Clinical Kidney Journal
Background Late-stage chronic kidney disease (LS-CKD) can be defined by glomerular filtration rate (GFR) 0–30 mL/min. It is a period of risk for medication discrepancies because of frequent hospitalizations, fragmented medical care, inadequate comm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f8f47a386b1b6c2c38f03b207d636db
http://europepmc.org/articles/PMC6070123
http://europepmc.org/articles/PMC6070123
Autor:
Jia H. Ng, Jamie S. Hirsch, Azzour Hazzan, Rimda Wanchoo, Hitesh H. Shah, Deepa A. Malieckal, Daniel W. Ross, Purva Sharma, Vipulbhai Sakhiya, Steven Fishbane, Kenar D. Jhaveri, Mersema Abate, Hugo Paz Andrade, Richard L. Barnett, Alessandro Bellucci, Madhu C. Bhaskaran, Antonio G. Corona, Bessy Suyin Flores Chang, Mark Finger, Michael Gitman, Candice Halinski, Shamir Hasan, Azzour D. Hazzan, Susana Hong, Yuriy Khanin, Aireen Kuan, Varun Madireddy, Deepa Malieckal, Abdulrahman Muzib, Gayatri Nair, Vinay V. Nair, Jia Hwei Ng, Rushang Parikh, Mala Sachdeva, Richard Schwarz, Pravin C. Singhal, Nupur N. Uppal
Publikováno v:
American Journal of Kidney Diseases
Rationale & Objective Outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19) and acute kidney injury (AKI) are not well understood. The goal of this study was to investigate the survival and kidney outcomes of these patients. Stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a89d57fac74a90302c620499d0c6699e
https://doi.org/10.1053/j.ajkd.2020.09.002
https://doi.org/10.1053/j.ajkd.2020.09.002
Autor:
Azzour D. Hazzan, Susana Hong, Hitesh H. Shah, Steven Fishbane, Rimda Wanchoo, Vipulbhai Sakhiya
Publikováno v:
Kidney International. 86:34-39
Treatment of anemia remains an important component in the care of patients with nondialysis chronic kidney disease (CKD) and end-stage renal disease (ESRD). Erythropoietin-stimulating agents (ESAs) remains a key anemia treatment strategy in this pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f275d5dc23fdf54cc44f7b71a184724
https://doi.org/10.1038/ki.2013.528
https://doi.org/10.1038/ki.2013.528
Autor:
Shailaja Chidella, Steve Fishbane, Anna T. Mathew, Kenar D. Jhaveri, Geoffrey A. Block, Azzour D. Hazzan, Lisa Rosen, John A. Wagner
Publikováno v:
American Journal of Nephrology. 40:451-457
Background/Aims: Dialysis patients are at increased risk for hip fractures. Because changes in treatment of metabolic bone disease in this population may have impacted bone fragility, this study aims to analyze the longitudinal risk for fractures in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e9ba681efd10d5f341816c44c1702ed
https://doi.org/10.1159/000369039
https://doi.org/10.1159/000369039
Autor:
Azzour D. Hazzan, Steven Fishbane, Vipul Sakhiya, Dennis G. Moledina, Shayan Shirazian, Mary Schanler, Chinmay Patel, Myriam Kline
Publikováno v:
Journal of Renal Nutrition. 23:428-431
Objective Pruritus is a common problem among hemodialyzed patients. Its causes are poorly understood, and, as a result, itching is often attributed to elevated serum phosphorus and other disorders of bone and minerals. The primary purpose of this stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba37fbabf8d0693bd67cba999bee8da9
https://doi.org/10.1053/j.jrn.2013.08.002
https://doi.org/10.1053/j.jrn.2013.08.002
Publikováno v:
Advances in chronic kidney disease. 23(4)
Advanced CKD is a period of CKD that differs greatly from earlier stages of CKD in terms of treatment goals. Treatment during this period presents particular challenges as further loss of kidney function heralds the need for renal replacement therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be707dc3cff41a1d62eeb0ca99b1213d
https://pubmed.ncbi.nlm.nih.gov/27324673
https://pubmed.ncbi.nlm.nih.gov/27324673
Publikováno v:
Seminars in nephrology. 36(2)
Management of anemia remains an integral component in the care of patients with chronic kidney disease undergoing hemodialysis. In addition to erythropoiesis-stimulating agents, iron-replacement agents remain a key strategy for anemia treatment in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcee88a2381cbe96befce306119d28c4
https://pubmed.ncbi.nlm.nih.gov/27236134
https://pubmed.ncbi.nlm.nih.gov/27236134